SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-012797
Filing Date
2022-12-19
Accepted
2022-12-19 21:16:51
Documents
1
Period of Report
2022-12-16

Document Format Files

Seq Description Document Type Size
1 form4-12202022_021242.html 4  
1 form4-12202022_021242.xml 4 3718
  Complete submission text file 0001415889-22-012797.txt   5213
Mailing Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Issuer) CIK: 0001701541 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 79 TW ALEXANDER DRIVE 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK NC 27709
Business Address
Velleca Mark A. (Reporting) CIK: 0001706847 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39200 | Film No.: 221472716